Recombinant Human E2F2 Protein，His

E2F2 is a member of the E2F family of transcription factors, which play a crucial role in the regulation of cell cycle progression, DNA synthesis, and the maintenance of cellular proliferation. Its function is primarily associated with the control of genes required for the transition from the G1 phase to the S phase of the cell cycle. E2F2 can act both as a repressor and an activator of target genes, depending on its interactions with various proteins, such as retinoblastoma (Rb) protein and other regulatory factors. Research on E2F2 has garnered interest due to its implications in cancer biology, where dysregulation of E2F family members can lead to uncontrolled cell division and tumor progression. Studies have shown that E2F2 expression levels correlate with the growth and invasiveness of various tumors, making it a potential biomarker for cancer prognosis. Additionally, E2F2’s role in apoptosis and differentiation highlights its importance in maintaining normal cellular functions. Understanding the regulatory mechanisms governing E2F2 activity, along with its interactions with other proteins, can provide insights into novel therapeutic strategies for cancer treatment and potentially other diseases associated with cell cycle dysregulation. Moreover, research involving E2F2 may uncover its contributions to normal developmental processes and stem cell biology, further emphasizing its multifaceted role in both health and disease.